Progress, Potential, and Possibilities Podcast / Show Dr. Elizabeth Garner, MD, MPH - Chief Scientific Officer, U.S., Ferring Pharmaceuticals - President American Medical Women's Association (AMWA) - The Future Of Women's Health, Fertility And Fem-Tech
Dr. Elizabeth Garner, MD, MPH, ( https://ferringusa.com/?team=elizabeth-garner-md-mph ) is Chief Scientific Officer, U.S., Ferring Pharmaceuticals, a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and maternal health, as well as in specialty areas within gastroenterology and urology, including microbiome therapeutics and orthopedics, and has been developing treatments for mothers and babies for over 50 years. Dr. Garner has broad responsibilities for U.S. Clinical Development, Medical Affairs, Pharmacovigilance, Project Planning and Regulatory Affairs. Dr. Garner has nearly 30 years of experience in medicine and industry. Prior to joining Ferring in 2022, she held chief medical officer roles for ObsEva, a biotechnology company focused on women’s health, and Agile Therapeutics, a women’s healthcare company in the contraceptive space. Earlier, she held leadership roles in medical affairs at Myriad Genetics Laboratories and clinical development at Abbott Laboratories and Merck Research Laboratories. Dr. Garner holds a medical degree from Harvard Medical School and has practiced in obstetrics, gynecology, gynecologic oncology, and internal medicine at Brigham and Women’s Hospital and Massachusetts General Hospital. In addition, she holds a master’s degree in public health from Harvard’s T.H. Chan School of Public Health and a bachelor’s degree in music from Mount Holyoke College in Massachusetts. Dr. Garner is a member of the Boards of Directors (BOD) of Kezar Life Sciences (KZR), a publicly traded company developing novel therapies for autoimmune diseases and cancer, Sermonix Pharmaceuticals, which is developing targeted therapies for breast cancer, and is also on the board of Medicines360, a non-profit pharma company. She also serves on the BOD, and is President of, the American Medical Women’s Association ( https://www.amwa-doc.org/about-amwa/leadership/ ), whose mission is to advance women in medicine, advocate for equity, and ensure excellence in health care.